Abstract |
Gastrointestinal infection with Shiga toxins producing enterohemorrhagic Escherichia coli causes the spectrum of gastrointestinal and systemic complications, including hemorrhagic colitis and hemolytic uremic syndrome, which is fatal in ∼10% of patients. However, the molecular mechanisms of Stx endocytosis by enterocytes and the toxins cross the intestinal epithelium are largely uncharacterized. We have studied Shiga toxin 1 entry into enterohemorrhagic E. coli-infected intestinal epithelial cells and found that bacteria stimulate Shiga toxin 1 macropinocytosis through actin remodeling. This enterohemorrhagic E. coli-caused macropinocytosis occurs through a nonmuscle myosin II and cell division control 42 (Cdc42)-dependent mechanism. Macropinocytosis of Shiga toxin 1 is followed by its transcytosis to the basolateral environment, a step that is necessary for its systemic spread. Inhibition of Shiga toxin 1 macropinocytosis significantly decreases toxin uptake by intestinal epithelial cells and in this way provides an attractive, antibiotic-independent strategy for prevention of the harmful consequences of enterohemorrhagic E. coli infection.
|
Authors | Valeriy Lukyanenko, Irina Malyukova, Ann Hubbard, Michael Delannoy, Edgar Boedeker, Chengru Zhu, Liudmila Cebotaru, Olga Kovbasnjuk |
Journal | American journal of physiology. Cell physiology
(Am J Physiol Cell Physiol)
Vol. 301
Issue 5
Pg. C1140-9
(Nov 2011)
ISSN: 1522-1563 [Electronic] United States |
PMID | 21832249
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Actins
- Shiga Toxin 1
- Myosin Type II
- cdc42 GTP-Binding Protein
|
Topics |
- Actins
(metabolism)
- Cell Line
- Colon
(metabolism, microbiology)
- Enterohemorrhagic Escherichia coli
- Escherichia coli Infections
(metabolism, microbiology)
- Humans
- Intestinal Mucosa
(metabolism, microbiology)
- Myosin Type II
(metabolism)
- Pinocytosis
- Shiga Toxin 1
(metabolism)
- Transcytosis
- cdc42 GTP-Binding Protein
(metabolism)
|